About
Truvaga is a handheld vagus nerve stimulation device designed to activate the vagus nerve, a major communication pathway between the brain and vital organs. The company's approach centers on non-invasive bioelectronic technology backed by over 20 years of clinical research. In just two minutes per session, Truvaga stimulates the vagus nerve to shift the body from a stress response into a state of calm, supporting stress reduction, improved sleep quality, and mental clarity without drugs or invasive procedures.
The Truvaga Plus is the company's flagship consumer product, featuring a rechargeable design with unlimited two-minute sessions and app-guided guidance. The device includes a proprietary electrode spray for conductivity and is designed for portability and daily integration. According to the company's data, 94% of users reported feeling calmer and happier within 30 days of use. The technology targets the cervical branch of the vagus nerve directly through transcutaneous stimulation, making it accessible for at-home use without medical supervision.
Truvaga positions itself as evidence-based rather than speculative, emphasizing that vagus nerve therapy itself is well-studied across clinical trials and real-world applications. The company's mission reflects a belief that chronic stress has become culturally normalized despite its effects on sleep, memory, learning, and overall health. By making vagus nerve stimulation accessible through a consumer device, Truvaga aims to provide people with a practical tool for autonomic nervous system regulation and sustained wellness.
Longevity Contribution
- Rechargeable, unlimited-session design with app-enabled guidance, eliminating battery replacement and session limits
- Backed by 20+ years of clinical research in bioelectronic medicine with proprietary stimulation parameters
- Two-minute session format designed for easy daily integration into existing routines
- 30-day risk-free trial with money-back guarantee, reducing adoption barriers for new users